|
SEP15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.214100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.461800E-02 |
| Normal-vs-Stage2 |
2.943200E-03 |
| Normal-vs-Stage3 |
3.386700E-04 |
| Normal-vs-Stage4 |
9.52020000000164E-05 |
| Stage1-vs-Stage2 |
7.409800E-02 |
| Stage1-vs-Stage3 |
5.108300E-02 |
| Stage1-vs-Stage4 |
1.188140E-02 |
| Stage2-vs-Stage3 |
7.190800E-01 |
| Stage2-vs-Stage4 |
8.983000E-01 |
| Stage3-vs-Stage4 |
5.736800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.593400E-04 |
| Normal-vs-AfricanAmerican |
6.896000E-01 |
| Normal-vs-Asian |
2.931500E-02 |
| Caucasian-vs-AfricanAmerican |
1.713020E-01 |
| Caucasian-vs-Asian |
7.555000E-01 |
| AfricanAmerican-vs-Asian |
3.734400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.024280E-03 |
| Normal-vs-Female |
2.575400E-03 |
| Male-vs-Female |
4.246800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.001500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.483600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.12829999996145E-06 |
| Normal-vs-Age(81-100Yrs) |
3.767700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.380600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.797000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.734400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.842020E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.007600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.396000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.703600E-02 |
| Classical-VS-Follicular |
4.254100E-02 |
| Classical-VS-Other |
9.689400E-01 |
| Classical-VS-Normal |
3.010000E-02 |
| Tall-VS-Follicular |
9.467800E-01 |
| Tall-VS-Other |
5.141800E-01 |
| Tall-VS-Normal |
1.178610E-03 |
| Follicular-VS-Other |
5.132800E-01 |
| Follicular-VS-Normal |
1.361970E-03 |
| Other-VS-Normal |
6.128800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.624400E-04 |
| Normal-vs-N1 |
6.244600E-04 |
| N0-vs-N1 |
4.016600E-01 |
|
|
